Extra (standby) subjects [Design Issues]

posted by brijeshmaroj – 2011-02-08 08:16 (5616 d 22:58 ago) – Posting: # 6577
Views: 5,346

Hi there,

In BA/ BE studies, we usually dose approximately n=10% more than the required sample size to take care of the withdrawals and drop outs to meet the required sample size at the end of the study. But are there any guidelines for ethical considerations for this? And if those extra subjects also complete the study, what is the justification for including/ excluding these extra subjects' samples for bioanalysis and including their data in statistical analysis. Do we have any regulatory guidelines for this?

Thank you,
Dr. Brijesh.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
148 visitors (0 registered, 148 guests [including 41 identified bots]).
Forum time: 08:15 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5